Eisai Launches "CHOCOLA EC", an Over the Counter Product, With Natural Type Vitamin E & Vitamin C
Tokyo (August 5, 1998) - Eisai Co., Ltd. of Tokyo (President and CEO: Haruo Naito) today announced the August 6th launch of another product, CHOCOLA EC, in the much beloved CHOCOLA family of OTC products. CHOCOLA EC is beneficial against liver spots, freckles, sensitivity to cold in the hands and feet, numbness, and stiff shoulders.
CHOCOLA EC, which contains natural type vitamin E and vitamin C, relieves liver spots, freckles, and skin coloration resulting from sunburn and skin irritation by suppressing the production of melanin. In addition, within the body, the high biological activity of natural type vitamin E has been shown to promote blood flow thus providing relief to stiff shoulders and sensitivity to cold in the hands and feet.
CHOCOLA EC comes in an easy to take low calorie sugar-free powder that melts in the mouth. The thin convenient packets can be easily carried to the office or outdoors.
With an increase in the opportunities for outdoor sports resulting in direct exposure to the sun, countermeasures against liver spots and freckles is a major concern for many women. In addition, with the increase of office air conditioning and personal computer usage, there is also a concern of sensitivity to cold in the hands and feet and stiff shoulders. CHOCOLA EC is a ideal vitamin product for those having concerns about these types of problems.
Sales objectives for CHOCOLA EC for this fiscal year are 300 million and those for the entire CHOCOLA family 7.5 billion.
For additional information about CHOCOLA EC and the entire CHOCOLA product series, please contact Eisai's Consumer Hotline. Toll Free Number (in Japan): 0120-161-454. Monday-Friday 9 a.m. - 8 p.m. and Saturday/Sunday/Holiday 9 a.m. - 5 p.m.
Eisai Co., Ltd. is a research-based human health care company which discovers, develops and markets products in more than 30 countries. Through its global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of worldwide health care systems. The Company reported sales of about $2.3 billion in 1997 with approximately 15 percent of sales spent on research and development.